Señales en vivo de NGM | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 abr 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.78% compare to its pairs and should correct upwards.

NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer...

Stats
Volumen de hoy	2.21M
Volumen promedio	1.07M
Capitalización de mercado	128.53M
EPS	$-0.330 ( Q4 \| 2024-03-11 )
Próxima fecha de ganancias	( $0 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.890 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00400 (0.26%)

AADI -5.88%

ABCL 2.20%

ABCM 0.04%

ABEO -3.08%

ABIO -2.77%

ABOS 0.93%

ABSI 4.42%

ABUS -1.31%

ABVX -2.56%

ACAD -0.64%

ACER -17.95%

ACET -8.84%

ACGN 1.29%

ACHL -2.89%

ACHV 2.59%

ACIU -1.00%

ACLX -0.24%

ACRV -4.29%

ACST -3.58%

ACXP 3.23%

ADAG 7.14%

ADAP -3.97%

ADGI 0.87%

ADIL -3.51%

ADMA -1.54%

ADPT 0.59%

ADTX -3.47%

ADVM 1.01%

ADXN -1.60%

AEON -5.61%

AEZS -2.19%

AFMD -2.62%

AGEN -4.44%

AGIO -2.98%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 7.94%

AKRO -2.43%

AKTX -5.23%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -0.92%

ALGS -1.09%

ALKS 1.61%

ALLK -10.17%

ALLO -2.50%

ALLR -3.37%

ALNA 3.16%

ALNY 2.09%

ALPN 0.02%

ALPX 0.00%

ALRN -3.00%

ALT -15.59%

ALVR -1.65%

ALXN 0.00%

ALXO -10.50%

ALZN -1.05%

AMRN -4.13%

AMTI -3.13%

ANAB 1.55%

ANEB 7.20%

ANGN 0.00%

ANIX -4.05%

ANL -0.14%

ANNX 1.53%

ANPC -3.15%

APGE 2.08%

APGN 8.48%

APGNW 30.65%

APLM -6.42%

APLS 0.07%

APLT 0.45%

APM 0.21%

APOP 0.38%

APRE -3.13%

APTO 2.55%

APTX 3.17%

APVO 3.35%

ARAV -13.39%

ARCT -6.81%

ARDS -12.13%

ARDX 1.50%

ARGX -1.26%

ARNA 0.00%

ARPO -0.90%

ARQT -3.23%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.76%

ARWR -2.27%

ASLN -2.23%

ASMB -7.14%

ASND -2.31%

ATAI -3.70%

ATHA 10.05%

ATHE 0.08%

ATHX -33.50%

ATNF 0.99%

ATOS 1.94%

ATRA -6.23%

ATXI 1.94%

ATXS -0.33%

AUPH -1.08%

AURA 4.70%

AUTL -3.45%

AVBP -3.03%

AVEO 0.00%

AVIR -1.75%

AVRO -1.41%

AVTE -0.69%

AVTX -4.26%

AVXL -5.68%

AXLA 0.00%

AXSM -2.39%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.77%

BCAB -7.84%

BCDA -1.02%

BCDAW -46.41%

BCEL 0.00%

BCLI -0.18%

BCRX 1.64%

BCTX 12.76%

BCTXW 11.64%

BCYC 0.95%

BDRX -4.42%

BDTX 0.00%

BEAM 2.43%

BFRA -2.91%

BGNE -3.01%

BIOR -5.65%

BIVI 1.72%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -2.45%

BLTE -1.65%

BLU 0.03%

BLUE -4.28%

BMEA -14.59%

BMRN 0.33%

BNOX 4.44%

BNTC -5.76%

BNTX -2.20%

BOLD -9.71%

BOLT -1.36%

BPMC -2.47%

BPTH -6.67%

BPTS -13.47%

BRNS -0.37%

BRTX -4.72%

BTAI 11.86%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 0.48%

CADL 1.06%

CALA 0.00%

CALC -8.27%

CALT -1.87%

CAPR -0.22%

CARA -12.44%

CARM 6.09%

CASI -1.24%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.67%

CCCC -1.70%

CCXI 0.00%

CDAK 0.00%

CDIO -4.74%

CDIOW -28.57%

CDMO -1.27%

CDMOP 0.04%

CDT -13.82%

CDTTW -39.60%

CDTX -6.28%

CDXC 9.43%

CDXS 9.66%

CELC -2.79%

CELU -1.00%

CELUW -15.56%

CERC -1.68%

CERE -1.52%

CERO -4.60%

CEROW -20.36%

CFRX -27.95%

CGEM 0.49%

CGEN -3.31%

CGON -2.90%

CGTX -3.41%

CHMA -6.00%

CHRS 5.06%

CINC 0.00%

CING -3.75%

CINGW 34.95%

CKPT -0.96%

CLBS -16.75%

CLDX -0.28%

CLGN -0.60%

CLLS -3.11%

CLNN -2.47%

CLNNW 0.00%

CLRB 7.04%

CLSD -3.20%

CLSN -0.68%

CLVS 0.00%

CMMB -1.96%

CMND 3.23%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.55%

CNCE 0.00%

CNSP -35.21%

CNST 0.00%

CNTA 1.12%

CNTB 0.00%

CNTX -9.59%

COCP -2.40%

COEPW 32.45%

COGT -2.64%

CORT 3.98%

COYA -2.60%

CPRX -0.46%

CRBP -1.94%

CRBU -7.95%

CRDF 3.54%

CRGX -2.01%

CRIS -4.34%

CRNX -5.97%

CRSP 1.22%

CRTX 2.63%

CRVO -7.90%

CRVS 0.56%

CSBR -3.50%

CTCX -11.20%

CTIC 0.06%

CTMX 0.00%

CTNM 4.37%

CTXR -7.15%

CUE -4.50%

CVAC -4.94%

CVKD -1.26%

CWBR 2.80%

CYAD -12.96%

CYCC 19.53%

CYCCP 6.99%

CYCN 7.81%

CYT -2.27%

CYTK -2.12%

CYTO 0.91%

DARE -0.30%

DAWN 0.30%

DBTX -0.81%

DBVT -2.08%

DFFN 10.28%

DICE 0.06%

DMAC 30.97%

DNLI -1.74%

DNTH -2.27%

DOMH -1.06%

DRMA -3.31%

DRMAW -1.25%

DRNA 0.00%

DRTS 2.31%

DRTSW -8.92%

DRUG -0.10%

DSGN -2.42%

DTIL 1.04%

DYAI 9.68%

EARS -1.77%

EDIT -3.22%

EDSA 4.14%

EFTR -3.93%

EFTRW -55.56%

EIGR -9.21%

ELAB -2.41%

ELDN 6.72%

ELEV -2.49%

ELOX 6.15%

ELTX -5.29%

ELVN -1.35%

ELYM 10.04%

ENGN -1.23%

ENGNW -22.50%

ENLV -0.72%

ENOB 1.79%

ENSC 6.53%

ENTA -0.33%

ENTO -4.97%

ENTX 1.60%

ENVB 3.10%

EPIX 2.89%

EPRX -2.87%

EPZM 0.00%

EQ -1.14%

EQRX -2.09%

EQRXW 0.00%

ERAS 5.77%

ERNA -1.11%

ERYP 1.30%

ESLA -1.08%

ESLAW 1.62%

ETNB -7.00%

ETON 2.44%

ETTX 0.00%

EVAX 1.42%

EVGN 2.16%

EVLO 0.00%

EWTX 0.52%

EXAI 0.19%

EXEL 0.54%

EYEG -0.67%

EYEN -3.08%

EYPT -0.85%

FATE -12.37%

FBIO 0.59%

FBIOP 0.87%

FBLG -10.20%

FBRX -0.04%

FDMT -4.50%

FENC -2.90%

FGEN -9.83%

FHTX 5.34%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.72%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.89%

FULC 3.18%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.45%

GANX -2.31%

GBIO -1.06%

GBT 0.01%

GDTC 2.03%

GERN -1.55%

GHRS -4.10%

GLMD -2.48%

GLPG -1.91%

GLSI 11.18%

GLTO -3.90%

GLUE -2.64%

GLYC -12.60%

GMAB -0.43%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -4.87%

GNPX -3.92%

GNTA 3.94%

GOSS -7.00%

GOVX -8.41%

GOVXW 10.89%

GPCR -5.21%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -3.78%

GRTX 2.19%

GTHX 2.27%

GUTS 0.69%

GXGXW 41.67%

GYRE -5.65%

HALO -0.76%

HARP 0.09%

HCWB -7.15%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX 0.08%

HOOK 0.00%

HOTH -2.86%

HOWL 0.00%

HRMY 3.32%

HRTX 9.18%

HSTO 0.00%

HUMA 1.42%

HUMAW -6.25%

IBRX -6.88%

ICCC -0.44%

ICPT 0.21%

ICU 18.87%

ICUCW 4.86%

ICVX -0.91%

IDRA -23.04%

IDYA -3.43%

IFRX -1.23%

IGMS -2.05%

IKNA -2.38%

IKT 0.00%

IMAB -0.87%

IMCR -4.15%

IMGN 0.02%

IMGO 0.00%

IMMP 5.32%

IMMX -5.17%

IMNM 4.25%

IMNN -1.77%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.50%

IMTX -1.50%

IMTXW 6.00%

IMUX -9.19%

IMV 0.00%

IMVT -4.51%

INAB -1.80%

INBX -3.11%

INCY -2.14%

INDP 8.72%

INFI -52.38%

INKT 0.00%

INM 0.77%

INMB 1.96%

INO 1.56%

INSM -1.05%

INTS -3.14%

INVA 0.87%

INZY 1.14%

IOBT -7.09%

IONS 1.49%

IOVA -4.02%

IPA 0.50%

IPHA 2.54%

IPSC -3.91%

IRON -2.47%

ISEE 0.38%

ITOS 2.87%

ITRM 1.67%

IVA 6.96%

IVVD 0.00%

JAGX 1.31%

JANX -4.03%

JAZZ -0.85%

JNCE 0.00%

JSPR -1.50%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.96%

KALV -2.08%

KDNY 0.22%

KMPH -0.34%

KNSA -2.32%

KNTE -0.38%

KOD -9.49%

KPRX -4.08%

KPTI -8.71%

KRBP -10.00%

KRON 0.74%

KROS -0.22%

KRRO 0.09%

KRTX 0.03%

KRYS 0.82%

KTRA 9.55%

KTTA -0.65%

KTTAW 82.57%

KURA 0.54%

KYMR -4.04%

KYTX -6.07%

KZIA 4.51%

KZR -3.84%

LABP 0.57%

LBPH 1.57%

LBPS 0.00%

LBPSW 14.81%

LEGN 3.15%

LENZ -3.67%

LEXX 0.77%

LEXXW 23.81%

LGND -1.37%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -9.42%

LIXT -9.81%

LIXTW 45.97%

LJPC -0.32%

LMNL 0.12%

LOGC 0.52%

LPCN -3.68%

LPTX -3.30%

LQDA 0.33%

LRMR -0.21%

LSTA -1.16%

LTRN 6.48%

LUMO 0.67%

LVTX -4.64%

LXEO -13.22%

LXRX -1.18%

LYEL -36.03%

LYRA 3.49%

MACK 0.10%

MBIO -11.26%

MBRX -1.43%

MCRB 0.05%

MDGL -1.67%

MDNA -13.16%

MDWD 4.25%

MDXG -1.77%

MEIP 0.00%

MESO -1.48%

MGNX -5.13%

MGTA -7.74%

MGTX 0.00%

MGX 1.88%

MIRM -0.84%

MIRO 0.59%

MIST 3.08%

MITO 0.00%

MLEC -6.54%

MLECW 3.08%

MLND -5.36%

MLTX 1.23%

MLYS -8.87%

MNKD -0.95%

MNMD 2.83%

MNOV 0.70%

MNPR -9.09%

MOLN 0.76%

MOR 0.45%

MORF -3.16%

MREO -0.29%

MRKR 1.50%

MRNA -11.01%

MRNS -7.35%

MRSN -3.81%

MRTX -0.17%

MRUS 0.37%

MRVI 1.02%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.95%

MYMD 2.16%

NAMS 0.41%

NAMSW 0.64%

NAUT -1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 10.66%

NCNA -1.45%

NERV -0.32%

NEXI 1.47%

NGM -1.28%

NGNE 2.93%

NKGN 9.24%

NKGNW -20.91%

NKTR 1.40%

NKTX -2.61%

NLSP 7.41%

NLSPW 26.67%

NMRA -1.71%

NMTR -42.97%

NOVN -24.84%

NRBO 13.38%

NRIX -1.63%

NRSN 2.60%

NRSNW 0.00%

NRXP -10.41%

NRXPW 18.33%

NRXS 1.20%

NTBL 2.67%

NTEC -12.45%

NTHI 0.00%

NTLA -4.54%

NTRBW -31.07%

NUVL -1.98%

NVAX -6.36%

NVCT -8.45%

NVIV -34.28%

NXTC -5.88%

NYMX -0.05%

OABI 2.37%

OABIW 2.60%

OBIO 0.15%

OBSV 0.00%

OCEA -3.52%

OCGN 8.47%

OCS 0.25%

OCUL 1.07%

OCUP 0.33%

ODT -4.27%

OKYO 1.72%

OLMA -5.71%

OMER -1.80%

OMGA -2.08%

ONCO 9.93%

ONCR -3.08%

ONCS 31.87%

ONCT -2.04%

ONCY 2.97%

ONTX -0.47%

ONVO 1.00%

OPNT 0.00%

OPT -3.09%

ORGS 1.65%

ORIC -1.63%

ORMP 14.73%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -0.69%

OVID 1.80%

OYST 0.00%

PALI -0.43%

PASG 0.00%

PBLA -7.50%

PBM -3.26%

PBYI 6.08%

PCSA -0.97%

PCVX 0.74%

PDSB -3.80%

PEPG 0.89%

PGEN -7.19%

PHAR 1.99%

PHAS 0.00%

PHAT -1.06%

PHIO -3.55%

PHIOW 36.47%

PHVS -6.55%

PHXM -5.20%

PIRS 0.11%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -3.11%

PLUR 10.43%

PMN -5.55%

PMVP -1.19%

PNT 0.16%

PPBT 2.13%

PRAX 6.33%

PRDS 0.93%

PRLD -2.37%

PROG -3.47%

PROK 1.79%

PRQR -0.60%

PRTA -3.90%

PRTC -2.46%

PRTG 0.09%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -10.37%

PSTX -4.26%

PTCT -0.37%

PTE -0.82%

PTGX 0.16%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 4.90%

QLGN -7.17%

QNCX 2.04%

QNRX -1.34%

QSI -28.31%

QSIAW -9.50%

QTTB 4.94%

QURE -1.35%

RAIN -1.63%

RANI 4.01%

RAPT -0.97%

RARE 1.71%

RCKT -10.73%

REGN -0.19%

RENB -2.48%

REPL -1.25%

RETA 0.02%

REUN -0.89%

REVB -7.44%

REVBU 3.46%

REVBW 4.38%

RGLS -4.67%

RGNX -6.57%

RIGL -6.24%

RLAY -7.12%

RLMD 0.00%

RLYB -6.04%

RNA 2.46%

RNAC 2.87%

RNAZ -0.96%

RNXT 0.89%

ROIV -2.40%

ROIVW 4.56%

RPHM -2.48%

RPRX -1.19%

RPTX -1.17%

RUBY 2.70%

RVLP -32.05%

RVMD -1.06%

RVMDW -30.00%

RVNC -0.43%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.61%

RYTM -6.74%

RYZB 0.02%

RZLT 3.36%

SABS -3.41%

SABSW -5.53%

SAGE -0.55%

SANA -3.14%

SAVA -3.78%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 3.56%

SCPH 12.12%

SCPS 0.00%

SEEL -2.79%

SEER -1.76%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -5.19%

SGMT -4.83%

SGTX -2.56%

SIOX 22.63%

SLDB -1.72%

SLGL 5.23%

SLN -8.22%

SLNO 1.59%

SLRX 0.40%

SLS -4.27%

SMMT -3.00%

SNDX 1.74%

SNGX 3.02%

SNPX -2.77%

SONN 0.20%

SPPI -0.49%

SPRB -1.64%

SPRC -2.99%

SPRO 0.00%

SRNE 0.00%

SRPT -0.73%

SRRA 0.00%

SRRK -2.85%

SRZN 6.13%

STAB 0.00%

STOK -7.38%

STRO -1.84%

STSA 0.00%

STTK 6.61%

SURF -0.93%

SVRA 1.05%

SWTX -0.49%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -6.90%

TARS -2.13%

TBPH 0.12%

TCBP 8.77%

TCDA 0.00%

TCON -2.03%

TCRR 0.00%

TCRT -1.21%

TCRX -1.29%

TECH -1.33%

TENX -0.32%

TERN -8.00%

TFFP -12.18%

TGTX -7.61%

THRX 0.12%

TIL -1.22%

TLC 0.00%

TLSA -4.41%

TNGX -4.21%

TNXP -10.00%

TNYA -4.73%

TPST 4.85%

TRDA -4.54%

TRVI 1.53%

TRVN 2.74%

TSHA -17.24%

TSVT -4.26%

TTNP -6.21%

TVTX 3.64%

TYRA -6.95%

UBX -2.13%

UNCY -4.00%

URGN 4.18%

UTHR -0.03%

VACC 11.36%

VALN -3.15%

VAXX 113.13%

VBIV -0.78%

VBLT -8.77%

VCEL 1.94%

VCNX 5.26%

VCYT -1.01%

VERA -4.29%

VERU 0.54%

VERV -4.02%

VIGL 1.61%

VINC 2.81%

VIR -1.30%

VIRI -4.25%

VIRX -1.75%

VKTX -0.86%

VLON -13.04%

VNDA -2.61%

VOR -7.26%

VRCA 0.14%

VRDN -3.53%

VRNA -2.33%

VRPX -0.48%

VRTX 0.04%

VSTM 4.42%

VTGN -2.11%

VTVT -0.18%

VTYX -2.93%

VXRT -2.09%

VYGR -0.26%

VYNE -7.51%

VYNT 7.78%

WINT -2.72%

WVE -8.28%

XBIO 1.03%

XBIT 1.88%

XCUR 1.26%

XENE -1.16%

XERS 4.76%

XFOR 4.17%

XLO 1.33%

XLRN 0.00%

XNCR 0.41%

XOMA -7.75%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.72%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.97%

ZNTL -0.95%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-04-05	Tcg Opportunity Iii Gp, Llc	Buy	1 000	Common Stock
2024-04-05	Tcg Opportunity Iii Gp, Llc	Sell	44 000	Common Stock
2024-04-05	Column Group Gp, Lp	Buy	1 000	Common Stock
2024-04-05	Column Group Gp, Lp	Sell	44 000	Common Stock
2024-04-05	Column Group L P	Buy	1 000	Common Stock

INSIDER POWER
-56.91
Last 100 transactions
Buy: 3 241 050 \| Sell: 9 885 031

Correlación (AI algo v.1.1b): Undervalued: 0.78% $1.562 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Volumen Correlación

Largo: -0.36 (neutral)

Corto: 0.00 (neutral)

Signal:(48.109) Neutral

NGM Biopharmaceuticals Correlación

10 Correlaciones Más Positivas
EGLE	0.872

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NGM Biopharmaceuticals Correlación - Moneda/Commodity

-0.78
( moderate negative )

-0.40
( neutral )

0.00
( neutral )

0.08
( neutral )

NGM Biopharmaceuticals Finanzas

Annual	2023
Ingresos:	$4.42M
Beneficio Bruto:	$2.20M (49.72 %)
EPS:	$-1.730

FY	2023
Ingresos:	$4.42M
Beneficio Bruto:	$2.20M (49.72 %)
EPS:	$-1.730

FY	2022
Ingresos:	$55.33M
Beneficio Bruto:	$49.35M (89.19 %)
EPS:	$-1.990

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.555

Financial Reports:

No articles found.

NGM Biopharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

NGM Biopharmaceuticals

NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); and MK-3655, an agonistic antibody that activates fibroblast growth factor receptor 1c-beta-klotho, which is in Phase IIb clinical trials for use in the treatment of type 2 diabetes and NASH. Its products under development also comprise NGM120, an antagonist antibody that binds GFRAL that is in Phase I/II clinical trials; NGM621, an immunoglobulin 1 monoclonal antibody in Phase II clinical trials for the treatment of geographic atrophy; NGM707, an immunoglobulin-like transcript 2/ immunoglobulin-like transcript 4 dual antagonist monoclonal antibody that is in Phase I/II clinical trials for the treatment of patients with advanced solid tumors; and NGM831 and NGM438 for the treatment of advanced solid tumors. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp.; and a collaboration agreement with Merck & Co., Inc. to focus primarily on the development of novel medicines for unmet patient needs in retinal and CVM diseases, including heart failure. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California.